What is Allurion?
Allurion offers a comprehensive weight-loss program centered around its swallowable, procedureless gastric balloon, the Allurion Smart Capsule. The program is augmented by the Allurion Virtual Care Suite, which includes a mobile app for consumers and a provider-facing platform with an AI-driven insights engine. This integrated approach aims to provide customized, monitored, and managed weight-loss therapy. The company's technology is designed to support individuals in achieving healthier weight outcomes through a combination of innovative devices and robust virtual support, positioning it as a key player in the digital health and wellness market.
How much funding has Allurion raised?
Allurion has raised a total of $281.3M across 16 funding rounds:
Private Equity
$6M
Multiple Rounds
$52M
Series B
$34M
Debt
$1M
Debt
$1M
Debt
$25M
Stock Offering
$100M
Debt
$48M
Share Placement
$2.3M
Stock/Share Issuance
$5M
Private Equity (2016): $6M backed by Romulus Capital
Private Equity (2017): $19M, investors not publicly disclosed
Series C (2017): $27M led by Romulus Capital and IDO Investments
Debt (2017): $6M supported by Silicon Valley Bank
Series B (2020): $34M featuring IDO Investments, Novalis LifeSciences, Bridge Bank, and Romulus Capital
Debt (2020): $1M backed by PPP
Debt (2021): $1M with participation from PPP
Debt (2021): $25M led by Runway Growth Capital LLC
Stock Issuance/Offering (2023): $100M, investors not publicly disclosed
Debt (2024): $48M featuring RTW Investments
Share Placement (2024): $2.3M, investors not publicly disclosed
Stock/Share Issuance (2025): $5M, investors not publicly disclosed
Key Investors in Allurion
Romulus Capital
Romulus Capital is an early-stage venture capital firm that focuses on leading Seed and Series A rounds for B2B companies and deep technology firms. They are known for their hands-on approach and hunger for innovative technology investments.
Silicon Valley Bank
SVB Financial Group provides a range of financial services including commercial and private banking, asset management, and investment services, primarily supporting technology and innovation-focused companies.
IDO Investments
IDO Investments is a technology investment firm based in Oman, focused on accelerating the growth of a knowledge-based economy by investing in established growth-stage startups with disruptive and innovative solutions.
What's next for Allurion?
With the recent major strategic investment and substantial overall capital raised, Allurion is poised for significant advancements. The company is likely to focus on expanding its global reach, enhancing its technological capabilities, and further integrating its AI platform for more personalized patient care. Continued investment in research and development for its swallowable gastric balloon and virtual care suite will be crucial. The enterprise-level funding suggests a strategic phase focused on scaling operations, potentially through new market entries or strategic partnerships, solidifying its leadership in the competitive weight-loss technology landscape.
See full Allurion company page
